Vysis
美國雅培Vysis公司 www.abbottmolecular.com
INNOVATION IS IN OUR DNA
As a leader in molecular diagnostics and the analysis of DNA, RNA, and proteins at the molecular level, Abbott Molecular has over 1000 employees dedicated to manufacturing and marketing more than 450 products worldwide in more than 130 countries. We are committed to advancing molecular testing solutions that guide life’s most profound decisions.
FIRST GENE-BASED TEST DESIGNED TO DETECT
THE HER-2 GENE FOUND IN MANY BREAST
CANCER PATIENTS
FIRST DRIED BLOOD SPOT TEST FOR HIV EARLY
INFANT DIAGNOSIS - CE MARK
FIRST FDA APPROVED TEST FOR IDENTIFICATION
OF ALK GENE REARRANGEMENTS
We are committed to exploring new clinical frontiers through the development and delivery of instrument and assay solutions designed to provide earlier disease diagnosis, selection of appropriate therapies and monitoring of disease recurrence. Our scientists are dedicated to producing quality and reliable products and our expanding portfolio brings multiples technologies that enable fast, accurate results.
